Intralesional methylprednisolone for Langerhans' cell histiocytosis of the orbit and cranium.
Intralesional methylprednisolone for Langerhans' cell histiocytosis of the orbit and cranium.
复制标题
病灶内注射甲基泼尼松龙治疗眼眶和颅骨的朗格汉斯细胞组织细胞增多症。
DOI：
--
复制
发表时间：
1987
影响因子：
1.2
通讯作者：
K. McClain
中科院分区：
文献类型：
--
作者：
J. Wirtschafter;M. Nesbit;P. Anderson;K. McClain
一个27个月大的女孩有一个快速扩大的眼眶额骨肿块由于朗格汉斯细胞组织细胞增生症。眼眶的CT显示一个包含不规则密度的眶侧肿块，通过骨的溶解性病变延伸到颅内腔。这是第一次报告的使用在眼眶内的病灶类固醇注射。五个月后，病变没有复发。这种治疗方法使病人免于放射治疗或开颅手术和刮宫术。
A 27-month-old girl had a rapidly expanding orbital frontal bone mass due to Langerhans' cell histiocytosis. The CT of the orbit showed a lateral orbital mass containing an irregular density that extended into the intracranial cavity through a lytic lesion of the bone. This is the first report of the use in the orbit of an intralesional steroid injection. Five months later the lesion had not recurred. This treatment spared the patient radiation therapy or a craniotomy with curettage.